Baicalin Inhibits TLR2/4 Signaling Pathway in Rat Brain Following Permanent Cerebral Ischemia
- 607 Downloads
Recent work from our laboratory demonstrated that baicalin attenuates inflammatory reaction and cerebral ischemia injury in rats. Toll-like receptor 2 and 4 (TLR2/4) and the downstream nuclear factor-kappa B (NF-κB) signaling pathway, which mediate the inflammatory reaction, are involved in the pathophysiological processes of cerebral ischemia. In this study, we investigated whether baicalin inhibits TLR2/4 signaling pathway in a rat model of permanent focal cerebral ischemia. Adult Sprague–Dawley rats underwent permanent middle cerebral artery occlusion (MCAO). Baicalin was administered by intraperitoneally injected twice at 2 and 12 h after the onset of ischemia. Cerebral infarct area and infarct volume were measured 24 h after MCAO. Expression of TLR2/4, NF-κB, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) were determined by RT-PCR or western blot. NO and PGE2 production in rat brain were measured 24 h after MCAO. Serum content of tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) were detected by ELISA. Baicalin reduced cerebral infarct area and infarct volume. Baicalin reduced the expression of TLR2/4 and NF-κB, decreased the expression and activity of iNOS and COX-2 in rat brain. Baicalin also attenuated the serum content of TNF-α and IL-1β. Our results suggest that baicalin inhibits the TLR2/4 signaling pathway in cerebral ischemia, which may be a mechanism underlying the baicalin’s neuroprotection.
KEY WORDSbaicalin cerebral ischemia cyclooxygenase-2 inducible nitric oxide synthase inflammation interleukin-1β nuclear factor-kappa B toll-like receptors tumor necrosis factor-α
The Key Laboratory (Neurosurgical Department) Fund from the Affiliated Union Hospital of Fujian Medical University, and the Professor Academic Development Fund of Fujian Medical University (JS0610) supported this work.
- 9.Tang, S.C., T.V. Arumugam, X. Xu, A. Cheng, M.R. Mughal, D.G. Jo, J.D. Lathia, D.A. Siler, S. Chigurupati, X. Ouyang, T. Magnus, S. Camandola, and M.P. Mattson. 2007. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proceedings of the National Academy of Sciences of the United States of America 104: 13798–13803.PubMedCrossRefGoogle Scholar
- 10.Ziegler, G., D. Harhausen, C. Schepers, O. Hoffmann, C. Rohr, V. Prinz, J. König, H. Lehrach, W. Nietfeld, and G. Trendelenburg. 2007. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochemical and Biophysical Research Communications 359: 574–579.PubMedCrossRefGoogle Scholar
- 11.Tu, X.K., W.Z. Yang, S.S. Shi, C.H. Wang, G.L. Zhang, T.R. Ni, C.M. Chen, R. Wang, J.W. Jia, and Q.M. Song. 2010. Spatio-temporal distribution of inflammatory reaction and expression of TLR2/4 signaling pathway in rat brain following permanent focal cerebral ischemia. Neurochemical Research 35: 1147–1155.PubMedCrossRefGoogle Scholar
- 12.Hoffmann, O., J.S. Braun, D. Becker, A. Halle, D. Freyer, E. Dagand, E. Dagand, S. Lehnardt, and J.R. Weber. 2007. TLR2 mediates neuroinflammation and neuronal damage. Journal of Immunology 178: 6476–6481.Google Scholar
- 24.Hua, F., J. Ma, T. Ha, Y. Xia, J. Kelley, D.L. Williams, R.L. Kao, I.W. Browder, J.B. Schweitzer, J.H. Kalbfleisch, and C. Li. 2007. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. Journal of Neuroimmunology 190: 101–111.PubMedCrossRefGoogle Scholar
- 26.Oto, J., A. Suzue, D. Inui, Y. Fukuta, K. Hosotsubo, M. Torii, S. Nagahiro, and M. Nishimura. 2008. Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients. Journal of Anesthesia 22: 207–212.PubMedCrossRefGoogle Scholar